BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 28315279)

  • 1. The Role of Sigma 1 Receptor as a Neuroprotective Target in Glaucoma.
    Mysona B; Kansara N; Zhao J; Bollinger K
    Adv Exp Med Biol; 2017; 964():299-307. PubMed ID: 28315279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sigma-1 Receptors and Neurodegenerative Diseases: Towards a Hypothesis of Sigma-1 Receptors as Amplifiers of Neurodegeneration and Neuroprotection.
    Nguyen L; Lucke-Wold BP; Mookerjee S; Kaushal N; Matsumoto RR
    Adv Exp Med Biol; 2017; 964():133-152. PubMed ID: 28315269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sigma-1 Receptor (S1R) Interaction with Cholesterol: Mechanisms of S1R Activation and Its Role in Neurodegenerative Diseases.
    Zhemkov V; Geva M; Hayden MR; Bezprozvanny I
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The involvement of the sigma-1 receptor in neurodegeneration and neurorestoration.
    Ruscher K; Wieloch T
    J Pharmacol Sci; 2015 Jan; 127(1):30-5. PubMed ID: 25704015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The sigma-1 receptor mediates the beneficial effects of pridopidine in a mouse model of Huntington disease.
    Ryskamp D; Wu J; Geva M; Kusko R; Grossman I; Hayden M; Bezprozvanny I
    Neurobiol Dis; 2017 Jan; 97(Pt A):46-59. PubMed ID: 27818324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.
    Peviani M; Salvaneschi E; Bontempi L; Petese A; Manzo A; Rossi D; Salmona M; Collina S; Bigini P; Curti D
    Neurobiol Dis; 2014 Feb; 62():218-32. PubMed ID: 24141020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bi-phasic dose response in the preclinical and clinical developments of sigma-1 receptor ligands for the treatment of neurodegenerative disorders.
    Maurice T
    Expert Opin Drug Discov; 2021 Apr; 16(4):373-389. PubMed ID: 33070647
    [No Abstract]   [Full Text] [Related]  

  • 8. Neuroprotection by (endo)Cannabinoids in Glaucoma and Retinal Neurodegenerative Diseases.
    Rapino C; Tortolani D; Scipioni L; Maccarrone M
    Curr Neuropharmacol; 2018; 16(7):959-970. PubMed ID: 28738764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotection of retinal ganglion cells by the sigma-1 receptor agonist pridopidine in models of experimental glaucoma.
    Geva M; Gershoni-Emek N; Naia L; Ly P; Mota S; Rego AC; Hayden MR; Levin LA
    Sci Rep; 2021 Nov; 11(1):21975. PubMed ID: 34753986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview of Sigma-1R Subcellular Specific Biological Functions and Role in Neuroprotection.
    Lachance V; Bélanger SM; Hay C; Le Corvec V; Banouvong V; Lapalme M; Tarmoun K; Beaucaire G; Lussier MP; Kourrich S
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid toxicity is enhanced after pharmacological or genetic invalidation of the σ
    Maurice T; Strehaiano M; Duhr F; Chevallier N
    Behav Brain Res; 2018 Feb; 339():1-10. PubMed ID: 29129596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between Sigma-1 receptor and BDNF in the visual system.
    Mysona BA; Zhao J; Smith S; Bollinger KE
    Exp Eye Res; 2018 Feb; 167():25-30. PubMed ID: 29031856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of sigma 1 receptor in organization of endoplasmic reticulum signaling microdomains.
    Zhemkov V; Ditlev JA; Lee WR; Wilson M; Liou J; Rosen MK; Bezprozvanny I
    Elife; 2021 May; 10():. PubMed ID: 33973848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sigma-1 (σ
    Maurice T; Goguadze N
    Handb Exp Pharmacol; 2017; 244():81-108. PubMed ID: 28275911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sigma receptors as potential therapeutic targets for neuroprotection.
    Nguyen L; Kaushal N; Robson MJ; Matsumoto RR
    Eur J Pharmacol; 2014 Nov; 743():42-7. PubMed ID: 25261035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging Benefits: Pathophysiological Functions and Target Drugs of the Sigma-1 Receptor in Neurodegenerative Diseases.
    Wu NH; Ye Y; Wan BB; Yu YD; Liu C; Chen QJ
    Mol Neurobiol; 2021 Nov; 58(11):5649-5666. PubMed ID: 34383254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sigma-1 receptor is a key genetic modulator in amyotrophic lateral sclerosis.
    Couly S; Khalil B; Viguier V; Roussel J; Maurice T; Liévens JC
    Hum Mol Genet; 2020 Mar; 29(4):529-540. PubMed ID: 31696229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rescue of Glaucomatous Neurodegeneration by Differentially Modulating Neuronal Endoplasmic Reticulum Stress Molecules.
    Yang L; Li S; Miao L; Huang H; Liang F; Teng X; Xu L; Wang Q; Xiao W; Ridder WH; Ferguson TA; Chen DF; Kaufman RJ; Hu Y
    J Neurosci; 2016 May; 36(21):5891-903. PubMed ID: 27225776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Sigma-1 receptor is an ER-localized type II membrane protein.
    Sharma N; Patel C; Shenkman M; Kessel A; Ben-Tal N; Lederkremer GZ
    J Biol Chem; 2021 Nov; 297(5):101299. PubMed ID: 34648767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peeking into Sigma-1 Receptor Functions Through the Retina.
    Mavlyutov TA; Guo LW
    Adv Exp Med Biol; 2017; 964():285-297. PubMed ID: 28315278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.